CureAge
1 known investors
Find your way into CureAge
CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.
Founders & leadership
Board
Investors · 1
Frequently asked questions
- What does CureAge do?
- CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.
- Who are CureAge's investors?
- CureAge's investors include Deep Science Ventures.